Kelly Walblay
- Co-authors
- Stéphanie BlackRichard A. TeranStephanie GretschUsha SamalaHyeree ChoiLivia NavonJanna L. KerinsMai T. Pho
- Topics
- Antibiotic Use and Resistance (4 papers)SARS-CoV-2 and COVID-19 Research (3 papers)Vaccine Coverage and Hesitancy (3 papers)
- Journals
- SHILAP Revista de lepidopterologíaThe Journal of Infectious DiseasesEmerging infectious diseases
- Partner nations
- United StatesPakistan
In The Last Decade
Kelly Walblay
11 papers receiving 155 citations
Peers
Comparison fields: 5 of 54
- Infectious Diseases 80
- Health 31
- Epidemiology 30
- Emergency Medicine 25
- Modeling and Simulation 23
Countries citing papers authored by Kelly Walblay
This map shows the geographic impact of Kelly Walblay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Walblay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Walblay more than expected).
Fields of papers citing papers by Kelly Walblay
This network shows the impact of papers produced by Kelly Walblay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Walblay. The network helps show where Kelly Walblay may publish in the future.
Co-authorship network of co-authors of Kelly Walblay
This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Walblay. A scholar is included among the top collaborators of Kelly Walblay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Walblay. Kelly Walblay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 59 | |
| 7 | 30 | |
| 8 | 2 | |
| 9 | 2 | |
| 10 | 22 | |
| 11 | 1 | |
| 12 | 39 |
About Kelly Walblay
Kelly Walblay is a scholar working on Applied Microbiology and Biotechnology, Health and Infectious Diseases, having authored 12 papers that have together received 159 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Vaccine Coverage and Hesitancy (3 papers). The work is most often cited by research in Toxicology (19 citations), Modeling and Simulation (23 citations) and Infectious Diseases (80 citations). Kelly Walblay has collaborated with scholars based in United States and Pakistan. Frequent co-authors include Stéphanie Black, Richard A. Teran, Stephanie Gretsch, Usha Samala, Hyeree Choi, Livia Navon, Janna L. Kerins, Mai T. Pho, Yen‐Tyng Chen and Erin D. Moritz. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Infectious Diseases and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.